drugset
drugset / Trial / NCT07617532

Efficacy and Safety of DNN.31.19.026 for Ocular Hypertension or Primary Open-Angle Glaucoma

NCT07617532 ↗

Phase 3 Not yet recruiting 336 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the safety and efficacy of DNN.31.19.026 compared with Cosopt® for the treatment of ocular hypertension or primary open-angle glaucoma.

Timeline

Start
2026-06
Primary completion
2028-03
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cosopt Unknown — Other
Subject Product DNN.31.19.026 Unknown — Other

Indications

ocular hypertension open-angle glaucoma